References
- Smith KJ. The prevention and treatment of cutaneous injury secondary to chemical warfare agents. Application of these finding to other dermatologic conditions and wound healing. Dermatol Clin 1999, 17, 41–60, viii.
- Balali-Mood M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 2005, 19, 297–315.
- Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F, Karkhane A. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 2004, 287, L1160–L1164.
- Aasted A, Darre E, Wulf HC. Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann Plast Surg 1987, 19, 330–333.
- Wormser U. Toxicology of mustard gas. Trends Pharmacol Sci 1991, 12, 164–167.
- Smith KJ, Skelton H. Chemical warfare agents: their past and continuing threat and evolving therapies. Part I of II. Skinmed 2003, 2, 215–221.
- Rosenthal DS, Simbulan-Rosenthal CM, Iyer S, Spoonde A, Smith W, Ray R, Smulson ME. Sulfur mustard induces markers of terminal differentiation and apoptosis in keratinocytes via a Ca2+–calmodulin and caspase-dependent pathway. J Invest Dermatol 1998, 111, 64–71.
- Yanagida J, Hozawa S, Ishioka S, Maeda H, Takahashi K, Oyama T, Takaishi M, Hakoda M, Akiyama M, Yamakido M. Somatic mutation in peripheral lymphocytes of former workers at the Okunojima poison gas factory. Jpn J Cancer Res 1988 Dec, 79(12), 1276–83.
- Petrali JP, Oglesby-Megee S. Toxicity of mustard gas skin lesions. Microsc Res Tech 1997, 37, 221–228.
- Renshaw B. Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. In: Chemical Warfare Agents and Related Chemical Problems. Parts 3–6, Vol. 9. Washington, DC: Office of Scientific Research and Development, National Deference Research Committee, 1945, pp. 478–520.
- Requena L, Requena C, Sánchez M, Jaqueti G, Aguilar A, Sánchez-Yus E, Hernández-Moro B. Chemical warfare. Cutaneous lesions from mustard gas. J Am Acad Dermatol 1988, 19, 529–536.
- Chilcott RP, Jenner J, Carrick W, Hotchkiss SA, Rice P. Human skin absorption of Bis-2-(chloroethyl)sulphide (sulphur mustard) in vitro. J Appl Toxicol 2000, 20, 349–355.
- Constance MP, David PR. Veterans at Risk: Health Effects of Mustard Gas and Lewisite. Washington, DC: National Academic Press, 1993, pp. 218–221.
- Emadi SN, Hosseini-Khalili A, Soroush MR, Davoodi SM, Aghamiri SS. Mustard gas scarring with specific pigmentary, trophic and vascular characteristics (case report, 16-year post-exposure). Ecotoxicol Environ Saf 2008, 69, 574–576.
- Lipsker D. What is poikiloderma? Dermatology (Basel) 2003, 207, 243–245.
- Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005, 214, 198–209.
- Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 1995, 32, 765–776.
- Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992, 128, 775–780.
- Emadi SN, Mortazavi M, Mortazavi H. Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: a long-term investigation. Arch Dermatol 2008, 144, 1059–1061.
- Emadi SN, Moeineddin F, Sorush MR. Urinary and cutaneous complications of sulphur mustard poisoning preceding pulmonary and ocular involvement: an unusual sequence of symptoms. Clin Exp Dermatol 2009, 34, e7–10.